Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders-Reference-Cited by-同舟云学术

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Published:2010-07-04 Issue:8 Volume:42 Page:722-726
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Ernst Thomas,Chase Andrew J,Score Joannah,Hidalgo-Curtis Claire E,Bryant Catherine,Jones Amy V,Waghorn Katherine,Zoi Katerina,Ross Fiona M,Reiter Andreas,Hochhaus Andreas,Drexler Hans G,Duncombe Andrew,Cervantes Francisco,Oscier David,Boultwood Jacqueline,Grand Francis H,Cross Nicholas C P

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.621.pdf

Reference39 articles.

1. Heim, S. & Mitelman, F. Cancer Cytogenetics (Wiley Blackwell, 2009).

2. Grand, F.H. et al. Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms. Blood 113, 6182–6192 (2009).

3. Gondek, L.P. et al. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. Blood 111, 1534–1542 (2008).

4. Heinrichs, S. et al. Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics. Leukemia 23, 1605–1613 (2009).

5. Gupta, M. et al. Novel regions of acquired uniparental disomy discovered in acute myeloid leukemia. Genes Chromosom. Cancer 47, 729–739 (2008).

Cited by 989 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How we diagnose Myelodysplastic syndromes;Frontiers in Oncology;2024-09-13

2. Histone H3 mutations and their impact on genome stability maintenance;Biochemical Society Transactions;2024-09-09

3. Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients;Journal of Hematology & Oncology;2024-08-19

4. Epigenetic Modulation by PRC2: Implications for Immune Regulation and Prognostic Outcomes in Breast Cancer;2024-07-24

5. Pharmacological targeting of the cancer epigenome;Nature Cancer;2024-06-27